N-Acetylcarnosine Sustained Drug Delivery Eye Drops to Control the Signs of Ageless Vision: Glare Sensitivity, Cataract Amelioration and Quality of Vision Currently Available Treatment for the Challenging 50,000-Patient Population
Clinical Interventions in Aging - New Zealand
doi 10.2147/cia.s4090
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2008
Authors
Publisher
Informa UK Limited